Zinc in PDB 5sep: Crystal Structure of Human Phosphodiesterase 10 in Complex with 2-[2- (4-Cyclopentyl-1-Methylimidazol-2-Yl)Ethyl]-5,8-Dimethyl-[1,2, 4]Triazolo[1,5-A]Pyrazine
Enzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2-[2- (4-Cyclopentyl-1-Methylimidazol-2-Yl)Ethyl]-5,8-Dimethyl-[1,2, 4]Triazolo[1,5-A]Pyrazine
All present enzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2-[2- (4-Cyclopentyl-1-Methylimidazol-2-Yl)Ethyl]-5,8-Dimethyl-[1,2, 4]Triazolo[1,5-A]Pyrazine:
3.1.4.17;
Protein crystallography data
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2-[2- (4-Cyclopentyl-1-Methylimidazol-2-Yl)Ethyl]-5,8-Dimethyl-[1,2, 4]Triazolo[1,5-A]Pyrazine, PDB code: 5sep
was solved by
C.Joseph,
K.Groebke-Zbinden,
J.Benz,
D.Schlatter,
M.G.Rudolph,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
43.53 /
2.10
|
Space group
|
H 3
|
Cell size a, b, c (Å), α, β, γ (°)
|
135.31,
135.31,
235.458,
90,
90,
120
|
R / Rfree (%)
|
17.4 /
22.6
|
Other elements in 5sep:
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2-[2- (4-Cyclopentyl-1-Methylimidazol-2-Yl)Ethyl]-5,8-Dimethyl-[1,2, 4]Triazolo[1,5-A]Pyrazine also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 2-[2- (4-Cyclopentyl-1-Methylimidazol-2-Yl)Ethyl]-5,8-Dimethyl-[1,2, 4]Triazolo[1,5-A]Pyrazine
(pdb code 5sep). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 4 binding sites of Zinc where determined in the
Crystal Structure of Human Phosphodiesterase 10 in Complex with 2-[2- (4-Cyclopentyl-1-Methylimidazol-2-Yl)Ethyl]-5,8-Dimethyl-[1,2, 4]Triazolo[1,5-A]Pyrazine, PDB code: 5sep:
Jump to Zinc binding site number:
1;
2;
3;
4;
Zinc binding site 1 out
of 4 in 5sep
Go back to
Zinc Binding Sites List in 5sep
Zinc binding site 1 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 2-[2- (4-Cyclopentyl-1-Methylimidazol-2-Yl)Ethyl]-5,8-Dimethyl-[1,2, 4]Triazolo[1,5-A]Pyrazine
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2-[2- (4-Cyclopentyl-1-Methylimidazol-2-Yl)Ethyl]-5,8-Dimethyl-[1,2, 4]Triazolo[1,5-A]Pyrazine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn801
b:37.0
occ:1.00
|
O
|
A:HOH991
|
2.1
|
32.5
|
1.0
|
NE2
|
A:HIS529
|
2.1
|
38.2
|
1.0
|
OD2
|
A:ASP564
|
2.2
|
35.6
|
1.0
|
NE2
|
A:HIS563
|
2.2
|
30.2
|
1.0
|
OD1
|
A:ASP674
|
2.2
|
33.7
|
1.0
|
O
|
A:HOH995
|
2.4
|
42.5
|
1.0
|
CD2
|
A:HIS563
|
3.0
|
30.5
|
1.0
|
CD2
|
A:HIS529
|
3.1
|
32.9
|
1.0
|
CG
|
A:ASP674
|
3.1
|
33.8
|
1.0
|
CG
|
A:ASP564
|
3.1
|
35.0
|
1.0
|
CE1
|
A:HIS529
|
3.2
|
35.7
|
1.0
|
CE1
|
A:HIS563
|
3.3
|
33.6
|
1.0
|
OD2
|
A:ASP674
|
3.4
|
37.3
|
1.0
|
OD1
|
A:ASP564
|
3.6
|
30.0
|
1.0
|
MG
|
A:MG802
|
3.7
|
32.2
|
1.0
|
CD2
|
A:HIS525
|
4.1
|
38.4
|
1.0
|
CG
|
A:HIS563
|
4.2
|
30.6
|
1.0
|
O
|
A:HOH1006
|
4.2
|
25.0
|
1.0
|
CG
|
A:HIS529
|
4.2
|
33.7
|
1.0
|
ND1
|
A:HIS529
|
4.3
|
34.7
|
1.0
|
ND1
|
A:HIS563
|
4.3
|
31.1
|
1.0
|
CB
|
A:ASP564
|
4.3
|
33.5
|
1.0
|
CB
|
A:ASP674
|
4.4
|
31.9
|
1.0
|
NE2
|
A:HIS525
|
4.5
|
37.5
|
1.0
|
O
|
A:HOH963
|
4.5
|
46.0
|
1.0
|
O
|
A:HOH931
|
4.5
|
26.1
|
1.0
|
CG2
|
A:VAL533
|
4.7
|
27.8
|
1.0
|
O
|
A:ASP674
|
4.8
|
31.2
|
1.0
|
CA
|
A:ASP674
|
4.9
|
29.3
|
1.0
|
O
|
A:HOH1035
|
4.9
|
55.0
|
1.0
|
|
Zinc binding site 2 out
of 4 in 5sep
Go back to
Zinc Binding Sites List in 5sep
Zinc binding site 2 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 2-[2- (4-Cyclopentyl-1-Methylimidazol-2-Yl)Ethyl]-5,8-Dimethyl-[1,2, 4]Triazolo[1,5-A]Pyrazine
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2-[2- (4-Cyclopentyl-1-Methylimidazol-2-Yl)Ethyl]-5,8-Dimethyl-[1,2, 4]Triazolo[1,5-A]Pyrazine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn801
b:35.3
occ:1.00
|
O
|
B:HOH975
|
2.1
|
27.4
|
1.0
|
OD2
|
B:ASP564
|
2.1
|
32.3
|
1.0
|
OD1
|
B:ASP674
|
2.1
|
32.6
|
1.0
|
NE2
|
B:HIS529
|
2.2
|
26.8
|
1.0
|
NE2
|
B:HIS563
|
2.2
|
25.5
|
1.0
|
O
|
B:HOH955
|
2.4
|
43.2
|
1.0
|
CD2
|
B:HIS563
|
3.0
|
29.5
|
1.0
|
CD2
|
B:HIS529
|
3.0
|
30.2
|
1.0
|
CG
|
B:ASP674
|
3.1
|
30.2
|
1.0
|
CG
|
B:ASP564
|
3.1
|
27.9
|
1.0
|
CE1
|
B:HIS529
|
3.2
|
29.0
|
1.0
|
CE1
|
B:HIS563
|
3.3
|
28.9
|
1.0
|
OD2
|
B:ASP674
|
3.3
|
34.0
|
1.0
|
OD1
|
B:ASP564
|
3.6
|
31.8
|
1.0
|
MG
|
B:MG802
|
3.7
|
29.2
|
1.0
|
CD2
|
B:HIS525
|
4.0
|
31.1
|
1.0
|
O
|
B:HOH1017
|
4.1
|
25.4
|
1.0
|
CG
|
B:HIS563
|
4.2
|
27.3
|
1.0
|
CG
|
B:HIS529
|
4.2
|
29.1
|
1.0
|
ND1
|
B:HIS529
|
4.3
|
26.1
|
1.0
|
ND1
|
B:HIS563
|
4.3
|
29.1
|
1.0
|
CB
|
B:ASP564
|
4.3
|
28.7
|
1.0
|
O
|
B:HOH985
|
4.4
|
51.5
|
1.0
|
CB
|
B:ASP674
|
4.4
|
31.3
|
1.0
|
NE2
|
B:HIS525
|
4.4
|
32.1
|
1.0
|
O
|
B:HOH961
|
4.5
|
30.5
|
1.0
|
O
|
B:HOH1055
|
4.5
|
57.7
|
1.0
|
CG2
|
B:VAL533
|
4.7
|
27.0
|
1.0
|
CA
|
B:ASP674
|
4.8
|
27.5
|
1.0
|
O
|
B:ASP674
|
4.9
|
28.1
|
1.0
|
|
Zinc binding site 3 out
of 4 in 5sep
Go back to
Zinc Binding Sites List in 5sep
Zinc binding site 3 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 2-[2- (4-Cyclopentyl-1-Methylimidazol-2-Yl)Ethyl]-5,8-Dimethyl-[1,2, 4]Triazolo[1,5-A]Pyrazine
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2-[2- (4-Cyclopentyl-1-Methylimidazol-2-Yl)Ethyl]-5,8-Dimethyl-[1,2, 4]Triazolo[1,5-A]Pyrazine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Zn801
b:35.9
occ:1.00
|
O
|
C:HOH977
|
2.1
|
27.1
|
1.0
|
NE2
|
C:HIS529
|
2.1
|
32.8
|
1.0
|
OD2
|
C:ASP564
|
2.2
|
31.8
|
1.0
|
NE2
|
C:HIS563
|
2.2
|
32.1
|
1.0
|
OD1
|
C:ASP674
|
2.2
|
28.6
|
1.0
|
O
|
C:HOH981
|
2.4
|
47.0
|
1.0
|
CD2
|
C:HIS563
|
3.0
|
31.1
|
1.0
|
CG
|
C:ASP674
|
3.1
|
30.2
|
1.0
|
CD2
|
C:HIS529
|
3.1
|
31.9
|
1.0
|
CE1
|
C:HIS529
|
3.2
|
33.0
|
1.0
|
CG
|
C:ASP564
|
3.2
|
30.1
|
1.0
|
OD2
|
C:ASP674
|
3.3
|
35.9
|
1.0
|
CE1
|
C:HIS563
|
3.3
|
32.1
|
1.0
|
OD1
|
C:ASP564
|
3.7
|
29.0
|
1.0
|
MG
|
C:MG802
|
3.8
|
31.8
|
1.0
|
CD2
|
C:HIS525
|
4.1
|
32.8
|
1.0
|
CG
|
C:HIS563
|
4.2
|
30.4
|
1.0
|
O
|
C:HOH1026
|
4.3
|
29.2
|
1.0
|
CG
|
C:HIS529
|
4.3
|
30.9
|
1.0
|
ND1
|
C:HIS529
|
4.3
|
30.9
|
1.0
|
ND1
|
C:HIS563
|
4.3
|
29.9
|
1.0
|
CB
|
C:ASP564
|
4.4
|
27.8
|
1.0
|
NE2
|
C:HIS525
|
4.4
|
33.5
|
1.0
|
CB
|
C:ASP674
|
4.4
|
32.4
|
1.0
|
O
|
C:HOH1019
|
4.4
|
42.3
|
1.0
|
O
|
C:HOH1039
|
4.5
|
60.0
|
1.0
|
O
|
C:HOH953
|
4.5
|
29.6
|
1.0
|
CG2
|
C:VAL533
|
4.7
|
30.5
|
1.0
|
CA
|
C:ASP674
|
4.8
|
33.7
|
1.0
|
O
|
C:ASP674
|
4.9
|
37.1
|
1.0
|
|
Zinc binding site 4 out
of 4 in 5sep
Go back to
Zinc Binding Sites List in 5sep
Zinc binding site 4 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 2-[2- (4-Cyclopentyl-1-Methylimidazol-2-Yl)Ethyl]-5,8-Dimethyl-[1,2, 4]Triazolo[1,5-A]Pyrazine
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2-[2- (4-Cyclopentyl-1-Methylimidazol-2-Yl)Ethyl]-5,8-Dimethyl-[1,2, 4]Triazolo[1,5-A]Pyrazine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Zn801
b:45.9
occ:1.00
|
O
|
D:HOH959
|
2.0
|
35.1
|
1.0
|
NE2
|
D:HIS529
|
2.2
|
40.5
|
1.0
|
OD2
|
D:ASP564
|
2.2
|
47.1
|
1.0
|
OD1
|
D:ASP674
|
2.2
|
44.7
|
1.0
|
NE2
|
D:HIS563
|
2.2
|
34.0
|
1.0
|
O
|
D:HOH940
|
2.3
|
49.9
|
1.0
|
CD2
|
D:HIS563
|
3.0
|
37.1
|
1.0
|
CG
|
D:ASP674
|
3.1
|
44.1
|
1.0
|
CD2
|
D:HIS529
|
3.2
|
42.8
|
1.0
|
CG
|
D:ASP564
|
3.2
|
41.4
|
1.0
|
CE1
|
D:HIS529
|
3.2
|
40.6
|
1.0
|
OD2
|
D:ASP674
|
3.3
|
47.9
|
1.0
|
CE1
|
D:HIS563
|
3.4
|
40.1
|
1.0
|
OD1
|
D:ASP564
|
3.7
|
41.6
|
1.0
|
MG
|
D:MG802
|
3.8
|
41.9
|
1.0
|
CD2
|
D:HIS525
|
4.1
|
43.1
|
1.0
|
O
|
D:HOH970
|
4.2
|
35.9
|
1.0
|
CG
|
D:HIS563
|
4.2
|
37.1
|
1.0
|
ND1
|
D:HIS529
|
4.3
|
42.9
|
1.0
|
CG
|
D:HIS529
|
4.3
|
38.0
|
1.0
|
CB
|
D:ASP564
|
4.3
|
41.0
|
1.0
|
ND1
|
D:HIS563
|
4.4
|
38.7
|
1.0
|
O
|
D:HOH944
|
4.4
|
56.3
|
1.0
|
O
|
D:HOH912
|
4.5
|
36.5
|
1.0
|
CB
|
D:ASP674
|
4.5
|
44.6
|
1.0
|
NE2
|
D:HIS525
|
4.5
|
49.1
|
1.0
|
CG2
|
D:VAL533
|
4.7
|
42.0
|
1.0
|
CA
|
D:ASP674
|
4.9
|
42.1
|
1.0
|
O
|
D:ASP674
|
4.9
|
44.5
|
1.0
|
|
Reference:
A.Tosstorff,
M.G.Rudolph,
J.C.Cole,
M.Reutlinger,
C.Kramer,
H.Schaffhauser,
A.Nilly,
A.Flohr,
B.Kuhn.
A High Quality, Industrial Data Set For Binding Affinity Prediction: Performance Comparison in Different Early Drug Discovery Scenarios. J.Comput.Aided Mol.Des. V. 36 753 2022.
ISSN: ESSN 1573-4951
PubMed: 36153472
DOI: 10.1007/S10822-022-00478-X
Page generated: Mon Oct 28 04:45:23 2024
|